NanoVibronix's subsidiary receives patent approval
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 04 2025
0mins
Patent Issuance: NanoVibronix's subsidiary, ENvue Medical, received U.S. Patent No. 12,402,953 B2 on September 2, which protects a method for overlaying electromagnetic navigation data onto real-time medical imaging.
Technological Impact: The patented technology aims to assist clinicians in visualizing the live path of feeding tubes or catheters on medical images, enhancing procedural accuracy and safety.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
